Results 151 to 160 of about 17,534 (188)
Some of the next articles are maybe not open access.
Intracranial atherosclerotic disease
Current Treatment Options in Neurology, 2009Symptomatic intracranial arterial stenosis carries one of the highest rates of recurrent stroke (10%-20% per year) despite antithrombotic therapy. Stroke prevention strategies for intracranial atherosclerotic disease follow the guidelines for secondary stroke prevention that target atherogenic risk factors.
Robert A, Taylor, Adnan I, Qureshi
openaire +3 more sources
Collateral Flow in Intracranial Atherosclerotic Disease
Translational Stroke Research, 2022Intracranial atherosclerotic disease (ICAD) is a major cause of ischemic stroke and transient ischemic attack (TIA) worldwide. The culprit of ICAD is frequently a high-grade intracranial atherosclerotic stenosis (ICAS) pertaining to the infarct territory, and by then, the ICAS is described as symptomatic.
Xinyi Leng, Thomas W. Leung
openaire +2 more sources
The contemporary management of intracranial atherosclerotic disease
Expert Review of Neurotherapeutics, 2016Intracranial atherosclerotic disease is the most common cause of cerebral vasculopathy and an important stroke etiology worldwide, with a higher prevalence in Asian, Hispanic and African ethnicities. Symptomatic intracranial atherosclerotic disease portends a recurrent stroke risk as high as 18% at one year.
Xinyi Leng +2 more
exaly +3 more sources
Intracranial atherosclerotic disease: An update
Annals of Neurology, 2009AbstractThe consensus conference on intracranial atherosclerosis provides a comprehensive review of the existing literature relevant to the epidemiology, diagnosis, prevention, and treatment of intracranial atherosclerosis, and identifies principles of management and research priorities.
Adnan I, Qureshi +9 more
openaire +2 more sources
Intracranial atherosclerotic disease
European Journal of Neurology, 2014Atherosclerotic disease of the intracranial arteries is responsible for at least 10% of ischaemic strokes worldwide. Symptomatic disease has been extensively studied in the past few years, using diagnostic methods including multi‐slice computed tomography and high resolution magnetic resonance imaging. A literature search was performed using PubMed and
V, Battistella, M, Elkind
exaly +3 more sources
Management of symptomatic intracranial atherosclerotic disease
Current Cardiology Reports, 2007Recently completed prospective studies have shown that with an incidence of recurrent stroke of approximately 10% per year, significant mortality, and other vascular comorbidities, symptomatic intracranial stenosis is a marker of aggressive vascular disease.
Tudor G, Jovin +2 more
openaire +2 more sources
Research Priorities for Intracranial Atherosclerotic Diseases
Journal of Neuroimaging, 2009ABSTRACT The current review summarizes the characteristics of existing experimental models for intracranial atherosclerosis in rabbits, pigs, and dogs with potential implications for research. New methodologies for understanding plaque morphology, and plaque quantitation and its prognostic implications are important for risk stratification in regards ...
Adnan I, Qureshi, Robert A, Taylor
openaire +2 more sources
Intracranial Atherosclerotic Disease
2012Optimal medical therapy for symptomatic intracranial stenosis includes antiplatelet therapy and aggressive management of atherosclerotic medical conditions such as diabetes, hypertension, hyperlipidemia, and cigarette smoking. Systemic anticoagulation is not indicated.
Daniel S. Ikeda +3 more
openaire +1 more source
Endovascular Treatment of Intracranial Atherosclerotic Disease
Neuroimaging Clinics of North America, 2013Stroke is the third leading cause of death in the United States. Intracranial atherosclerotic disease plays a role in cerebrovascular accidents, with well-characterized modifiable and nonmodifiable risk factors. Surgical bypass has so far not proved to be superior to medical therapy.
Christopher J, Lenart +2 more
openaire +2 more sources